The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Role of Brg1 and HDAC2 in GR trans -repression of the pituitary POMC gene and misexpression in Cushing disease
Open accessAbstract
Negative feedback regulation of the proopiomelanocortin ( POMC ) gene by the glucocorticoid (Gc) receptor (GR) is a critical feature of the hypothalamo–pituitary–adrenal axis, and it is in part exerted by trans -repression between GR and the orphan nuclear receptors related to NGFI-B. We now show that Brg1, the ATPase subunit of the Swi/Snf complex, is essential for this trans -repression and that Brg1 is required in vivo to stabilize interactions between GR and NGFI-B as well as between GR and HDAC2. Whereas Brg1 is constitutively present at the POMC promoter, recruitment of GR and HDAC2 is ligand-dependent and results in histone H4 deacetylation of the POMC locus. In addition, GR-dependent repression inhibits promoter clearance by RNA polymerase II. Thus, corecruitment of repressor and activator at the promoter and chromatin modification jointly contribute to trans -repression initiated by direct interactions between GR and NGFI-B. Loss of Brg1 or HDAC2 should therefore produce Gc resistance, and we show that ∼50% of Gc-resistant human and dog corticotroph adenomas, which are the hallmark of Cushing disease, are deficient in nuclear expression of either protein. In addition to providing a molecular basis for Gc resistance, these deficiencies may also contribute to the tumorigenic process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
Self-citationCombinatorial Control of Gene Expression by Nuclear Receptors and Coregulators
McKenna, N. J., & O'Malley, B. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00641-4 · Cited by 1,463 · cited 1×
“Mainly, Gc-dependent repression is mediated by GR, but without direct GR:DNA interactions as for GRactivated transcription (McKenna and O’Malley 2002).”
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Self-citationDNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068 · cited 2×
“Important aspects of glucocorticoid (Gc) action are exerted through repression of transcription (Helmberg et al. 1995; Reichardt et al. 1998), such as their anti-inflammatory action (Wintermantel et al. 2004).”
BackgroundDe Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898 · cited 1×
“It is, however, noteworthy that HDAC inhibitors appear to have beneficial effects on progression of different tumors (Drummond et al. 2005).”
BackgroundTargeted disruption of the three Rb-related genes leads to loss of G 1 control and immortalization
Sage, J., Mulligan, G. J., Attardi, L. D., Miller, A., Chen, S., Williams, B., Theodorou, E., & Jacks, T. (2000) · Genes & Development · doi:10.1101/gad.843200 · Cited by 582 · cited 6×
“Cell culture, transfection, and plasmids CV-1, C33A, SW13, and MEF TKO cells were cultured in DMEM supplemented with 10% fetal calf serum and antibiotics.”
MethodInfluentialNissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationGlucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
A General Introduction to Glucocorticoid Biology
Timmermans, S., Souffriau, J., & Libert, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01545 · Cited by 609
Pathogenesis of pituitary tumors
Melmed, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.40 · Cited by 466
Ratman, D., Vanden Berghe, W., Dejager, L., Libert, C., Tavernier, J., Beck, I. M., & De Bosscher, K. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.12.014 · Cited by 411
“In favour of this mechanism is the opposite observation for GR-mediated repression of NGFIB/Nurr77-regulated gene transcription, concomitant with a RNA PolII recruitment decrease (Bilodeau et al., 2006), arguing for a promoter- and transcription factor-dependency of these phenomena.”
BackgroundInfluentialMolecular Physiology of Pituitary Development: Signaling and Transcriptional Networks
Zhu, X., Gleiberman, A. S., & Rosenfeld, M. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00006.2006 · Cited by 370
Recurrent gain-of-function USP8 mutations in Cushing's disease
Ma, Z.-Y., Song, Z.-J., Chen, J.-H., Wang, Y.-F., Li, S.-Q., Zhou, L.-F., Mao, Y., Li, Y.-M., Hu, R.-G., Zhang, Z.-Y., et al. (2015) · Cell Research · doi:10.1038/cr.2015.20 · Cited by 368
Newton, R., & Holden, N. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038794 · Cited by 328
Nuclear Receptor Coregulators and Human Disease
Lonard, D. M., Lanz, R. B., & O’Malley, B. W. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0012 · Cited by 302
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
The BRG1 transcriptional coregulator
Trotter, K. W., & Archer, T. K. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06004 · Cited by 287
Crosstalk between the glucocorticoid receptor and other transcription factors: Molecular aspects
Kassel, O., & Herrlich, P. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.07.003 · Cited by 277
POMC: The Physiological Power of Hormone Processing
Harno, E., Gali Ramamoorthy, T., Coll, A. P., & White, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00024.2017 · Cited by 262
Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor
Clark, A. R., & Belvisi, M. G. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.004 · Cited by 209
“…complexity, the function of GR-interacting proteins as co-activators or co-repressors of transcription is not fixed but contingent, that is, dependent on cell and promoter context (; Rogatsky et al., 2002; Bilodeau et al., 2006; O'Malley & McKenna, 2008; Qiu et al., 2011; Santos et al., 2011).”
Early-Life Stress Reduces DNA Methylation of the Pomc Gene in Male Mice
Wu, Y., Patchev, A. V., Daniel, G., Almeida, O. F. X., & Spengler, D. (2014) · Endocrinology · doi:10.1210/en.2013-1868 · Cited by 142
Cushing’s syndrome: from physiological principles to diagnosis and clinical care
Raff, H., & Carroll, T. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.282871 · Cited by 137
Hypothalamic-pituitary – adrenal axis-feedback control
Keller‐Wood, M. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c140065 · Cited by 131
“Other evidence suggests GR interaction to prevent binding of the nuclear orphan receptor Nur77 at the POMC promoter involves activity of the histone deacetylase enzyme HDAC2 (19).”
Kelly, A., Bowen, H., Jee, Y.-K., Mahfiche, N., Soh, C., Lee, T., Hawrylowicz, C., & Lavender, P. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.010 · Cited by 83
Briassoulis, G., Damjanovic, S., Xekouki, P., Lefebvre, H., & Stratakis, C. A. (2011) · Endocrine Practice · doi:10.4158/ep11061.ra · Cited by 48
Self-citationMolecular Derangements and the Diagnosis of ACTH-Dependent Cushing’s Syndrome
Nieman, L. K. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab046 · Cited by 33
“As previously described, Brg1 and HDAC2 are recruited to the POMC promoter by an activated GR and act as transcriptional corepressors through protein interactions with GR (30).”
BackgroundSyndromes de Cushing : physiopathologie, étiologie et principes thérapeutiques
Chabre, O. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.02.001 · Cited by 21
Metadata
- Authors
- Bilodeau, S., Vallette-Kasic, S., Gauthier, Y., Figarella-Branger, D., Brue, T., Berthelet, F., Lacroix, A., Batista, D., Stratakis, C., Hanson, J., Meij, B., & Drouin, J.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2006-10-15
- Volume
- 20
- Issue
- 20
- Pages
- 2871-2886
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2078111498
- Cited by
- 242
- References
- 7
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.